Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
CA 2452580 A1 · Owner: Yancey, Robert John · Inventors: Yancey, Robert John; Keich, Robin Lee; Mcgavin, David Ross
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to Mycoplasma bovis vaccines and methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma bovis by administering to the animal an effective amount of a Mycoplasma bovis vaccine. The Mycoplasma bovis vaccine can be a whole or partial cell inactivated or modified live preparation a subunit vaccine, or a , nucleic acid or DNA vaccine. The Mycoplasma bovis vaccine administered in accordance with the present can be synthesized or recombinantly produced. The invention also related to combination vaccines methods of preparing , Mycoplasma bovis vaccines and kits.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 27, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 27, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 27, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.